Seban RD, Assie JB, Giroux-Leprieur E, Massiani MA, et al. Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy. Lung Cancer 2021;159:45-55.
PMID: 34311344